Congratulations to Indiana Lysis Technologies and The Bee Corp., two of the five finalists in the sixth annual BioCrossroads New Venture Competition.
Indiana Lysis Technologies was founded by Dr. Jeffrey Kline and Nathan Alves, faculty in the Indiana University School of Medicine’s Department of Emergency Medicine. Indiana Lysis Technologies is a drug-discovery company that is addressing the lack of safe options in treating blood clots in the lungs, or pulmonary embolisms.
The Bee Corp. was founded by IU alumni Ellie Symes, Simon Kuntz and Wyatt Wells. The Bee Corp. is an agriculture startup company that monitors conditions inside commercial beehives. It recently concluded a Series A round of funding.
The New Venture Competition was open to companies in several life sciences disciplines including agriculture technology, biotechnology, diagnostics, health information technology, medical devices and pharmaceuticals. The winner will receive $25,000 as well as access to the Indiana Seed Fund staff and its support resources. Second- and third-place winners will receive $15,000 and $10,000, respectively.
Results of the competition will be announced Monday, Oct. 9, at the Indiana Life Sciences Summit networking reception.